Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride is as safe for the heart as finasteride.

COC treatment improves hormone and metabolic levels in PCOS patients.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Low-dose oral minoxidil is as effective as or better than topical minoxidil for hair growth but may cause mild side effects.

Early-onset male hair loss may be linked to higher cardiovascular risk.

PCOS is linked to metabolic issues and infertility, needing more research.

Skin diseases like psoriasis, lupus, and others can increase heart disease risk due to factors like chronic inflammation and genetic susceptibility.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Acne is not a key diagnostic feature for PCOS, postadolescent men with acne may have insulin resistance, melanoma patients often have few moles, tumor size in CSCC indicates higher risk of serious outcomes, and hidradenitis suppurativa is linked to higher risk of heart problems and death.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Lifestyle changes are more effective than medication for reducing type 2 diabetes risk.

Gingivitis may increase a hormone linked to ovarian function in women with a certain ovary condition, and treating gum disease could help manage it.

Androgenetic alopecia is linked to higher cardiovascular and metabolic risks, possibly due to irisin resistance.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Taking 1 mg finasteride for a year reduces dihydrotestosterone levels in men with early hair loss, but doesn't change their metabolic state.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Men have more severe COVID-19 outcomes than women.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Oral testosterone therapy raises heart risk more than other methods.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.